Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1968 Jan;21(1):88–92. doi: 10.1136/jcp.21.1.88

Absorption of antibiotics during peritoneal dialysis in patients with renal failure

A C Buck 1,1, Simon L Cohen 1
PMCID: PMC473670  PMID: 4301499

Abstract

Cloxacillin, ampicillin, cephaloridine, kanamycin, and polymyxin B were administered singly in the dialysis fluid of patients having peritoneal dialysis for chronic renal failure. Therapeutic blood levels could be attained with all the drugs by the end of 12 hours of dialysis, using a concentration in the dialysis fluid which did not produce any local toxic symptoms. Absorption rates across the peritoneum were higher for cephaloridine, ampicillin, and cloxacillin than for kanamycin and polymyxin B.

The serum half-lives after termination of dialysis were in excess of 11 hours, except that for cloxacillin which had a half life of about 2·5 hours.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BULGER R. J., LINDHOLM D. D., MURRAY J. S., KIRBY W. M. EFFECT OF UREMIA ON METHICILLIN AND OXACILLIN BLOOD LEVELS. JAMA. 1964 Feb 1;187:319–322. doi: 10.1001/jama.1964.03060180005001. [DOI] [PubMed] [Google Scholar]
  2. Bulger R. J., Bennett J. V., Boen S. T. Intraperitoneal administration of broad-spectrum antibiotics in patients with renal failure. JAMA. 1965 Dec 13;194(11):1198–1202. [PubMed] [Google Scholar]
  3. COHN I., Jr, COTLAR A. M. Intraperitoneal kanamycin. Ann Surg. 1962 Apr;155:532–537. doi: 10.1097/00000658-196204000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greenberg P. A., Sanford J. P. Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate. Ann Intern Med. 1967 Mar;66(3):465–470. doi: 10.7326/0003-4819-66-3-465. [DOI] [PubMed] [Google Scholar]
  5. KUNIN C. M., FINLAND M. Restrictions imposed on antibiotic therapy by renal failure. Arch Intern Med. 1959 Dec;104:1030–1050. doi: 10.1001/archinte.1959.00270120186021. [DOI] [PubMed] [Google Scholar]
  6. MAXWELL M. H., ROCKNEY R. E., KLEEMAN C. R., TWISS M. R. Peritoneal dialysis. 1. Technique and applications. J Am Med Assoc. 1959 Jun 20;170(8):917–924. doi: 10.1001/jama.1959.03010080025004. [DOI] [PubMed] [Google Scholar]
  7. Mowbray J. F., Cohen S. L., Doak P. B., Kenyon J. R., Owen K., Percival A., Porter K. A., Peart W. S. Human cadaveric renal transplantation. Report of twenty cases. Br Med J. 1965 Dec 11;2(5475):1387–1394. doi: 10.1136/bmj.2.5475.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Palmer R. A., Newell J. E., Gray E. J., Quinton W. E. Treatment of chronic renal failure by prolonged peritoneal dialysis. N Engl J Med. 1966 Feb 3;274(5):248–254. doi: 10.1056/NEJM196602032740504. [DOI] [PubMed] [Google Scholar]
  9. ROSE H. D., ROTH D. A., KOCH M. L. SERUM TETRACYCLINE LEVELS DURING PERITONEAL DIALYSIS. Am J Med Sci. 1965 Jul;250:66–68. doi: 10.1097/00000441-196507000-00010. [DOI] [PubMed] [Google Scholar]
  10. Ruedy J. The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease. Can Med Assoc J. 1966 Feb 5;94(6):257–261. [PMC free article] [PubMed] [Google Scholar]
  11. THOMSON W. B., BUCHANAN A. A., DOAK P. B., PEART W. S. PERITONEAL DIALYSIS. Br Med J. 1964 Apr 11;1(5388):932–935. doi: 10.1136/bmj.1.5388.932. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES